<DOC>
	<DOCNO>NCT00002445</DOCNO>
	<brief_summary>The purpose study see safe effective use IM862 treat Kaposi 's sarcoma ( KS ) AIDS patient .</brief_summary>
	<brief_title>Safety Effectiveness Experimental Drug , IM862 , Treating Kaposi 's Sarcoma AIDS Patients</brief_title>
	<detailed_description>Patients stratify CD4 count , viral load , prior systemic chemotherapy . Patients randomize equally receive either IM862 placebo give intranasally every day . Patients see every 4 week 6 month disease progression evaluate toxicity efficacy . Quality life assess treatment , every month 6 month . At end 6-month study evaluation period , patient PR/CR ( responder ) remain study continue blind treatment additional 6 month . For patient stable disease ( non-responders ) , treatment assignment unblinded off-study IM862 compassionate use offer 6 month , regardless treatment group . For patient document progressive disease ( treatment failure ) , treatment assignment unblinded off-study IM862 offer 6 month patient placebo group . For treatment failure IM862 group , IM862 stop patient allow therapy option .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Have AIDSrelated Kaposi 's sarcoma . Have least 5 skin mouth sore require chemotherapy . Have take antiHIV drug least 8 week study entry change regimen . Are least 18 year old . Agree practice effective method birth control . Exclusion Criteria Patients eligible study : Have AIDSrelated opportunistic infection ( except genital herpes ) within 2 week study entry . Have another type cancer within past 2 year ( except certain type skin cancer , cervical cancer , anal cancer ) . Have severe chest cold . Have certain serious medical condition . Have receive certain medication , include chemotherapy , within past 4 week . Abuse alcohol drug . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Placebos</keyword>
	<keyword>Sarcoma , Kaposi</keyword>
	<keyword>Antineoplastic Agents</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Quality Life</keyword>
</DOC>